Rate-adaptive Pacing in Heart Failure with Preserved Ejection Fraction: Too Much of a Good Thing?

Overview

Journal Heart Rhythm O2

Date 2024 Jun 6

PMID 38840761

Authors

Alireza Oraii

Corentin Chaumont

Francis E Marchlinski

Matthew C Hyman

Affiliations

Soon will be listed here.

References

Pandey A, Shah S, Butler J, Kellogg Jr D, Lewis G, Forman D . Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021; 78(11):1166-1187. PMC: 8525886. DOI: 10.1016/j.jacc.2021.07.014. View

Wachter R, Schmidt-Schweda S, Westermann D, Post H, Edelmann F, Kasner M . Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure. Eur Heart J. 2009; 30(24):3027-36. PMC: 2792717. DOI: 10.1093/eurheartj/ehp341. View

Pal N, Sivaswamy N, Mahmod M, Yavari A, Rudd A, Singh S . Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction. Circulation. 2015; 132(18):1719-25. PMC: 4640051. DOI: 10.1161/CIRCULATIONAHA.115.017119. View

Silverman D, Rambod M, Lustgarten D, Lobel R, LeWinter M, Meyer M . Heart Rate-Induced Myocardial Ca Retention and Left Ventricular Volume Loss in Patients With Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2020; 9(17):e017215. PMC: 7660766. DOI: 10.1161/JAHA.120.017215. View

Haykowsky M, Brubaker P, John J, Stewart K, Morgan T, Kitzman D . Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J Am Coll Cardiol. 2011; 58(3):265-74. PMC: 3272542. DOI: 10.1016/j.jacc.2011.02.055. View

Munch G, Svendsen J, Damsgaard R, Secher N, Gonzalez-Alonso J, Mortensen S . Maximal heart rate does not limit cardiovascular capacity in healthy humans: insight from right atrial pacing during maximal exercise. J Physiol. 2013; 592(2):377-90. PMC: 3922500. DOI: 10.1113/jphysiol.2013.262246. View

Savarese G, Becher P, Lund L, Seferovic P, Rosano G, Coats A . Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2022; 118(17):3272-3287. DOI: 10.1093/cvr/cvac013. View

Anker S, Butler J, Filippatos G, Ferreira J, Bocchi E, Bohm M . Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021; 385(16):1451-1461. DOI: 10.1056/NEJMoa2107038. View

Nassif M, Windsor S, Borlaug B, Kitzman D, Shah S, Tang F . The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial. Nat Med. 2021; 27(11):1954-1960. PMC: 8604725. DOI: 10.1038/s41591-021-01536-x. View

10.

Tsao C, Aday A, Almarzooq Z, Alonso A, Beaton A, Bittencourt M . Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022; 145(8):e153-e639. DOI: 10.1161/CIR.0000000000001052. View

11.

Yuasa N, Obokata M, Harada T, Kagami K, Sorimachi H, Saito Y . Characterization and prognostic importance of chronotropic incompetence in heart failure with preserved ejection fraction. J Cardiol. 2023; 83(2):113-120. DOI: 10.1016/j.jjcc.2023.06.014. View

12.

Olson T, Johnson B, Borlaug B . Impaired Pulmonary Diffusion in Heart Failure With Preserved Ejection Fraction. JACC Heart Fail. 2016; 4(6):490-8. PMC: 4893169. DOI: 10.1016/j.jchf.2016.03.001. View

13.

Sohn D, Kim H, Park J, Chang H, Kim Y, Zo Z . Hemodynamic effects of tachycardia in patients with relaxation abnormality: abnormal stroke volume response as an overlooked mechanism of dyspnea associated with tachycardia in diastolic heart failure. J Am Soc Echocardiogr. 2007; 20(2):171-6. DOI: 10.1016/j.echo.2006.11.006. View

14.

Prasad A, Hastings J, Shibata S, Popovic Z, Arbab-Zadeh A, Bhella P . Characterization of static and dynamic left ventricular diastolic function in patients with heart failure with a preserved ejection fraction. Circ Heart Fail. 2010; 3(5):617-26. PMC: 3716372. DOI: 10.1161/CIRCHEARTFAILURE.109.867044. View

15.

Infeld M, Wahlberg K, Cicero J, Plante T, Meagher S, Novelli A . Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction: The myPACE Randomized Clinical Trial. JAMA Cardiol. 2023; 8(3):213-221. PMC: 9996402. DOI: 10.1001/jamacardio.2022.5320. View

16.

Dunlay S, Roger V, Redfield M . Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017; 14(10):591-602. DOI: 10.1038/nrcardio.2017.65. View

17.

Redfield M, Borlaug B . Heart Failure With Preserved Ejection Fraction: A Review. JAMA. 2023; 329(10):827-838. DOI: 10.1001/jama.2023.2020. View

18.

Palau P, Seller J, Dominguez E, Sastre C, Ramon J, de la Espriella R . Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction. J Am Coll Cardiol. 2021; 78(21):2042-2056. DOI: 10.1016/j.jacc.2021.08.073. View

19.

Sarma S, MacNamara J, Balmain B, Hearon Jr C, Wakeham D, Tomlinson A . Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?. Circulation. 2022; 147(5):378-387. PMC: 9892242. DOI: 10.1161/CIRCULATIONAHA.122.061828. View

20.

Becher P, Lund L, Coats A, Savarese G . An update on global epidemiology in heart failure. Eur Heart J. 2022; 43(32):3005-3007. DOI: 10.1093/eurheartj/ehac248. View